Carbamazepine and Enablex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carbamazepine (carbamazepine) and Enablex (darifenacin hydrobromide). Common drug interactions include blood albumin decreased among females and tremor among males.

The phase IV clinical study analyzes what interactions people have when they take Carbamazepine and Enablex. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Carbamazepine?

Carbamazepine has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 44,628 Carbamazepine users. Check the latest studies of Carbamazepine.

What is Enablex?

Enablex has active ingredients of darifenacin hydrobromide. It is often used in urge incontinence. eHealthMe is studying from 4,934 Enablex users. Check the latest studies of Enablex.



On Jul, 19, 2026

19 people who take Carbamazepine and Enablex together, and have interactions are studied.

Carbamazepine and Enablex drug interactions.

What are the common drug interactions of Carbamazepine and Enablex, by gender? *:

female:

  1. Blood albumin decreased
  2. Blood bilirubin increased
  3. Blood calcium decreased
  4. Body tinea (ringworm of the body)
  5. Constipation
  6. Dysgeusia (disorder of the sense of taste)
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Eye infection
  9. Fatigue (feeling of tiredness)
  10. Headache (pain in head)

male:

  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Urinary tract infection
  3. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  4. Obesity (having too much body fat)
  5. Overdose
  6. Skin lesion
  7. Suicide attempt
  8. Type 2 diabetes mellitus
  9. Upper respiratory tract infection
  10. Viral upper respiratory tract infection

What are the common drug interactions of Carbamazepine and Enablex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  5. Renal failure (kidney dysfunction)
  6. Renal tubular necrosis (death of kidney tubules)

50-59:

  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Urinary tract infection
  3. Abnormal behaviour
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Cardiac failure congestive
  6. Cellulitis (infection under the skin)
  7. Chest pain
  8. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  9. Insomnia (sleeplessness)
  10. Liver disorder (liver diseases)

60+:

  1. Blood albumin decreased
  2. Blood bilirubin increased
  3. Hypogeusia (reduced ability to taste things (to taste sweet, sour, bitter, or salty substances))
  4. Hyposmia (impairment of the sense of smell)
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  6. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  7. Muscle spasms (muscle contraction)
  8. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
  9. Myalgia (muscle pain)
  10. Nasopharyngitis (inflammation of the nasopharynx)

What are the existing conditions these people have? *

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 7 people, 36.84%
  2. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 7 people, 36.84%
  3. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 7 people, 36.84%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 36.84%
  5. Insomnia (sleeplessness): 7 people, 36.84%
  6. Sleep Disorder: 6 people, 31.58%
  7. Bipolar Disorder (mood disorder): 6 people, 31.58%
  8. High Blood Pressure: 5 people, 26.32%
  9. Osteoporosis (bones weak and more likely to break): 4 people, 21.05%
  10. Hypokalemia (low potassium): 4 people, 21.05%

* Approximation only. Some reports may have incomplete information.

Do you take Carbamazepine and Enablex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Carbamazepine and Enablex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Enablex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carbamazepine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enablex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on carbamazepine and darifenacin hydrobromide (the active ingredients of Carbamazepine and Enablex, respectively), and Carbamazepine and Enablex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: